[ad_1]
Pfizer’s stock gains after the drugmaker boosted its full-year profit outlook.
[ad_2]
Source link
Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut
By Daniel snow
By Daniel snow
By Daniel snow
[ad_1]
Pfizer’s stock gains after the drugmaker boosted its full-year profit outlook.
[ad_2]
Source link
